THE ASAHI SHIMBUN
May 13, 2021 at 18:22 JST
Takeharu Yamanaka, second from left, professor of health data science at Yokohama City University medical school, speaks about the findings of the Pfizer-BioNTech vaccine’s efficacy against variants at a news conference in Tokyo on May 12. (Kenta Noguchi)
About 90 percent of people fully inoculated by the Pfizer-BioNTech vaccine are well protected from variants of the novel coronavirus, having produced antibodies stimulated to better fight them off, Japanese researchers said on May 12. [Read More]
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.
